Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "diabetes-care"

61 News Found

Abbott unveils new diabetes care formula amid rising global diabetes crisis
News | November 16, 2025

Abbott unveils new diabetes care formula amid rising global diabetes crisis

The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health


Morepen launches Empamore for diabetes care with affordable treatment
News | March 18, 2025

Morepen launches Empamore for diabetes care with affordable treatment

Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health


Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
Biotech | May 09, 2022

Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)


GOQii launches first of its kind one-stop solution for Diabetes care in India
Startup | May 04, 2022

GOQii launches first of its kind one-stop solution for Diabetes care in India

An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching


Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Biopharma | June 24, 2026

Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore

Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia


Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
News | June 09, 2026

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter


Abbott secures CE mark for first dual glucose-ketone monitoring systems
Medical Device | May 29, 2026

Abbott secures CE mark for first dual glucose-ketone monitoring systems

Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk


Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial
Clinical Trials | May 13, 2026

Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial

Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care


India unveils first-ever national framework to tackle childhood diabetes
Policy | May 04, 2026

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system